Fcγ受体IIB通过IgG在IgA肾病中发挥差异性的细胞特异性调控作用
该研究在小鼠IgA肾病模型中采用三种细胞特异性FcγRIIB缺陷小鼠,发现巨噬细胞和树突状细胞特异性FcγRIIB缺陷可增强NOD样受体热蛋白结构域相关蛋白3炎症小体活化并加速疾病进展,而B细胞特异性缺陷无此效应;IgA免疫复合物经Toll样受体4/髓样分化初级反应蛋白88依赖方式诱导炎症小体活化,可能与Dectin-2交互作用有关。
要点
- FcγRIIB可减轻肾脏炎症,在IgA肾病中起保护性调控作用。
- 巨噬细胞和树突状细胞FcγRIIB缺陷加速小鼠IgA肾病进展。
- 靶向NOD样受体热蛋白结构域相关蛋白3、Toll样受体4和Dectin-2信号可能减轻FcγRIIB缺陷型IgA肾病。
核心结论
- 小鼠IgA肾病模型中巨噬细胞和树突状细胞FcγRIIB缺陷导致白蛋白尿增加、肾功能不全和肾损伤。
- FcγRIIB缺陷通过IgA免疫复合物以Toll样受体4/髓样分化初级反应蛋白88依赖方式增强NOD样受体热蛋白结构域相关蛋白3炎症小体活化。
研究设计与样本
- 采用小鼠IgA肾病模型及三种细胞类型特异性FcγRIIB缺陷小鼠:髓系细胞(CCAAT/增强子结合蛋白α Cre)、树突状细胞(CD11c Cre)和B细胞(CD19 Cre)floxed FcγRIIB小鼠,以及若干特定细胞模型。
主要发现
- 诱导性IgA肾病FcγRIIB敲除小鼠出现白蛋白尿大幅增加、肾功能受损和肾损伤。
- 巨噬细胞特异性和树突状细胞特异性FcγRIIB缺陷增强NOD样受体热蛋白结构域相关蛋白3炎症小体活化并加速IgA肾病发生和严重程度,而B细胞特异性FcγRIIB缺陷小鼠未观察到此效应。
- IgA免疫复合物经Toll样受体4/髓样分化初级反应蛋白88信号依赖方式诱导炎症小体活化,可能与Dectin-2交互作用有关。
关键数值与推荐
- 靶向NOD样受体热蛋白结构域相关蛋白3、Toll样受体4和Dectin-2信号可能减轻FcγRIIB缺陷型IgA肾病。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Fcγ receptor IIB (FcγRIIB) mitigates renal inflammation, highlighting its role as a protective modulator in IgA nephropathy. FcγRIIB deficiency in macrophages and dendritic cells accelerated disease progression in a mouse model of IgA nephropathy. Targeting NOD-, LRR- and pyrin domain–containing protein 3, toll-like receptor 4, and Dectin-2 signaling may alleviate FcγRIIB-deficient IgA nephropathy. BACKGROUND: IgA nephropathy is the most common form of GN and a leading cause of kidney failure. Ample evidence confirms the deposition of IgA and IgG, as well as the infiltration of mononuclear leukocytes in kidney biopsy specimens from IgA nephropathy patients. Previously, we established an experimental IgA nephropathy model in B-cell–deficient mice, implicating interactions between Fcγ receptor in the pathogenesis of IgA nephropathy. It is generally accepted that Fcγ receptor IIB (FcγRIIB) plays a regulatory role in humoral responses; we proposed that FcγRIIB might exert differential kidney-protective effects depending on cell type specificity, thereby influencing the progression and severity of IgA nephropathy. METHODS: We used a mouse model of IgA nephropathy and three different cell types of FcγRIIB-deficient mice, including CCAAT/enhancer-binding protein/α Cre (myeloid cells), CD11c Cre (dendritic cells), and CD19 Cre (B cells) in floxed FcγRIIB mice, as well as several specific cell models. RESULTS: In this study, we observed a large increase in albuminuria, kidney function impairment, and kidney injury in FcγRIIB knockout mice with induced IgA nephropathy. We demonstrated that macrophage-specific and dendritic cell–specific FcγRIIB deficiency enhanced the activation of NOD-, LRR- and pyrin domain–containing protein 3 inflammasome and accelerated the development and severity of IgA nephropathy, whereas this effect was not observed in mice with B-cell–specific FcγRIIB deficiency. Moreover, activation of the inflammasome was induced by IgA immune complexes dependent on toll-like receptor 4/myeloid differentiation primary response 88 signaling, potentially associated with crosstalk between Dectin-2. CONCLUSIONS: We found that FcγRIIB deficiency in macrophages and dendritic cells led to increased albuminuria, kidney dysfunction, and kidney injury in a mouse model of IgA nephropathy. FcγRIIB deficiency enhanced the activation of NOD-, LRR- and pyrin domain–containing protein 3 inflammasome through IgA immune complexes in a toll-like receptor 4/myeloid differentiation primary response 88–dependent manner.
引用
- Liu TY, Wu CC, Chen X, et al. Differential Cell-Specific, Regulatory Roles of Fc γ Receptor IIB through IgG in IgA Nephropathy. J Am Soc Nephrol. 2025. PMID: 40839400. doi:10.1681/ASN.0000000835
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。